CHA News Article

CHA Comments on Medicare Advantage, Prescription Drug Proposals

CHA has submitted the attached comment letter on the Centers for Medicare & Medicaid Services proposed rule that would establish new criteria for identifying protected classes of drugs, make revisions to promote competition in Part D plans, and provide changes to the regulatory definition of negotiated prices. CHA analyzed the changes and determined the proposal, if fully implemented, would reduce the number of protected classes by half. Neither the antidepressant nor the antipsychotic drug classes would meet the proposed criteria for special formulary protection, and CHA expressed concerns that the proposal would exacerbate compliance issues and place additional burden on the already overcrowded emergency rooms and inadequate behavioral health system in California.